Berna Erdal
Impact in
- Biochemistry top 10%
- Phytochemicals and Antioxidant Activities
- Biotechnology top 10%
- Microbial Inactivation Methods
Papers in
-
- COVID-19 Clinical Research Studies 3
-
- Salmonella and Campylobacter epidemiology 2
- Co-authors
- Seydi Yıkmış (7 shared papers)Okan Levent (4 shared papers)Esra Bozgeyi̇k (5 shared papers)Işıl Fidan (7 shared papers)Ayşe Kalkancı (4 shared papers)Semra Kuştımur (3 shared papers)Turgut İmir (4 shared papers)Eda Çelik Güzel (2 shared papers)
- Partner nations
- TürkiyeUnited StatesNorway
In The Last Decade
Berna Erdal
40 papers receiving 315 citations
Peers
Comparison fields: 5 of 85
- Biochemistry 53
- Biotechnology 50
- Food Science 80
- Infectious Diseases 46
- Parasitology 14
Countries citing papers authored by Berna Erdal
This map shows the geographic impact of Berna Erdal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Berna Erdal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Berna Erdal more than expected).
Fields of papers citing papers by Berna Erdal
This network shows the impact of papers produced by Berna Erdal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Berna Erdal. The network helps show where Berna Erdal may publish in the future.
Co-authors
The 25 scholars most cited alongside Berna Erdal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 38 | |
| 2 | 2022 | 30 | |
| 3 | 2022 | 29 | |
| 4 | 2016 | 25 | |
| 5 | 2022 | 16 | |
| 6 | 2021 | 13 | |
| 7 | 2011 | 12 | |
| 8 | 2022 | 12 | |
| 9 | 2024 | 10 | |
| 10 | 2022 | 10 | |
| 11 | 2022 | 10 | |
| 12 | 2021 | 9 | |
| 13 | 2014 | 9 | |
| 14 | [Investigation of West Nile virus seroprevalence in healthy blood donors]. | 2010 | 9 |
| 15 | 2022 | 8 | |
| 16 | 2022 | 8 | |
| 17 | 2020 | 7 | |
| 18 | 2008 | 6 | |
| 19 | 2024 | 5 | |
| 20 | 2020 | 5 |
About Berna Erdal
Berna Erdal is a scholar working on Infectious Diseases, Food Science, Molecular Biology, Oncology and Biochemistry, having authored 43 papers that have together received 317 indexed citations. Recurring topics across this work include Phytochemicals and Antioxidant Activities (5 papers), COVID-19 Clinical Research Studies (3 papers), Bee Products Chemical Analysis (3 papers), Gut microbiota and health (2 papers), Pomegranate: compositions and health benefits (2 papers), COVID-19 and Mental Health (2 papers), Antibiotic Resistance in Bacteria (2 papers) and Salmonella and Campylobacter epidemiology (2 papers). The work is most often cited by research in Biochemistry (53 citations), Biotechnology (50 citations), Food Science (80 citations), Infectious Diseases (46 citations) and Parasitology (14 citations). Berna Erdal has collaborated with scholars based in Türkiye, United States and Norway. Frequent co-authors include Seydi Yıkmış, Okan Levent, Esra Bozgeyi̇k, Işıl Fidan, Ayşe Kalkancı, Semra Kuştımur, Turgut İmir, Eda Çelik Güzel, John Chalmers and Patrik Midlöv. Their work appears in journals such as Gene, Mycoses, ACS Omega, Biology and Pathogens.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.